Submit manuscript...
Journal of
eISSN: 2473-0831

Analytical & Pharmaceutical Research

Research Article Volume 7 Issue 5

Development and validation of RP-HPLC method for determination of amoxicillin residues and application to NICOMAC coating machine

Hassouna MEM, Mohamed MA

Correspondence: Hassouna MEM, Chemistry Department, Faculty of Science 62514, Beni-Suef University, Egypt, Tel +2 01223861504, Fax -803

Received: October 06, 2018 | Published: October 18, 2018

Citation: Hassouna MEM, Mohamed MA. Development and validation of RP-HPLC method for determination of amoxicillin residues and application to NICOMAC coating machine. J Anal Pharm Res. 2018;7(5):586-594. DOI: 10.15406/japlr.2018.07.00287

Download PDF

Abstrat

The Cleaning Validation protocol plays an important role in the field of pharmaceutical industries; its main task is the verification of cleaning procedures to ensure that complete removal of product residues, degradation products, preservatives, excipients, cleaning agents and cross-contamination of the previous active ingredients. A new RP-HPLC method is evaluated for determination of Amoxicillin (AMO) residues in NICOMAC coating machine using Betabasic-C18 (4.6mm x 250mm) 5µm or equivalent, mobile phase of a mixture of 0.05M sodium dihydrogen phosphate: methanol (95:5v/v) adjusted to pH 4.4 with orthophosphoric acid at a flow rate of 1.5mL/min, injection volume 100μL and UV detection at 230nm. The retention time of AMO is 6.292 min and the total run time is 7.0 min. A Linear relationship is obtained in the range 0.03 to 6 ppm with a correlation coefficient of 0.9989, limit of detection 0.05μgmL-1 and limit of quantitation of 0.15μgmL-1. The overall recovery is 100±15%; the relative standard deviation for precision and intraday precision is less than 2.0 %. The validation of the method is performed according to ICH guidelines and USP requirements for new methods, which include accuracy, precision, specificity, LOD, LOQ, robustness, ruggedness, linearity and range.

Keywords: amoxicillin, cleaning validation, RP- HPLC, stability indicating method, NICOMAC coating machine, ICH

Abbreviations

AMO, amoxicillin trihydrate; DIW, deionized water; HDPE, High density polyethylene; FDA, Food and drug administration; API, active pharmaceutical ingredient

Introduction

AMO, is a semi-synthetic penicillin antibacterial drug derived from a fermentation product. Chemically, it is (2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl) acetyl] amino]-3,3-dimethyl-7-oxo-4- thia-1-azabicyclo [3.2.0] heptane-2-carboxylic acid trihydrate having a molecular formula of C16H19N3O5S.3H2O and its molecular weight is 419.4. AMO is a crystalline powder with white or almost white appearance. It is slightly soluble in water, very slightly soluble in ethanol (96%), practically insoluble in fatty oils. It dissolves in dilute acids and dilute solutions of alkali hydroxides.

It may be represented by the structural formula1 as illustrated in (Figure 1). Amoxicillin is stable in the presence of gastric acid and is rapidly absorbed after oral administration. The effect of food on its absorption from tablets and suspension has been partially investigated. The 400 and 875 mg formulations have been studied only when administered at the start of a light meal. However, food effect studies have not been performed with the 200 and 500mg formulations. Amoxicillin diffuses readily into most body tissues and fluids, except for brain and spinal fluid, especially when meninges are inflamed. Its half-life is 61.3 minutes. Most of the Amoxicillin is excreted unchanged in the urine; its excretion can be delayed by concurrent administration of probenecid. In blood serum, amoxicillin is approximately 20% protein-bound. It is similar to ampicillin in its bactericidal action against susceptible organisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell wall mucopeptide.2

Figure 1 Chemical structure of amoxicillin trihydrate.

AMO is official in British Pharmacopeia (BP),1 European Pharmacopeia (EP)3 and United States Pharmacopeia (USP) 4, they include HPLC method for its determination. It is still a limited number of analytical methods that are reported for the determination of AMO including kinetics degradation,5–7 spectrophotometric,8–13 UHPLC, UPLC and mass spectrometry,14–19 thin layer chromatography (TLC),20–22 capillary electrophoresis,23–26 high performance liquid chromatography (HPLC),27–31 in vitro dissolution studies,32–36 amoxicillin residues in animal tissues using SPE-LC,37 SPE-cation exchange,38 in eggs using HPLC-FLD,39 or HPLC-MS40 and in commercial meat and milk samples41 using HPLC-FLD.

According to the best of our knowledge there is no validated method for the determination of amoxicillin residues and application to cleaning machine in pharmaceutical industries. The present work describes the development and validation of an accurate and reliable RP-HPLC method for the determination of AMO residues and application to NICOMAC coating machine.

Experimental

Materials and reagents

Pure samples: Standard sample of AMO is kindly supplied by Hikma pharmaceutical industries company, Beni-Suef, Egypt with claimed purity of 98.2%.

Chemicals: Methanol HPLC-grade, sodium dihydrogen phosphate dihydrate and orthophosphoric acid are provided from (Scharlau, Spain).

Solvent preparation: Collect a sufficient quantity of fresh deionized water from the DIW loop in a suitable and clean container. Allow cooling to room temperature before use.

Solutions

Standard stock solutions of AMO (1000μg/mL): Weigh about the equivalent to 50mg of AMO from AMO (as trihydrate) working standard. Transfer completely to a 50-mL volumetric flask with aid of 35mL of deionized water. Shake for about 5 minutes, then complete to volume with deionized water.

Working standard solutions of AMO (1.0μg/mL): Accurately transfer 1.0mL from the stock standard solution of AMO into 1000mL volumetric flask, add diluent and sonicate to dissolve. Makeup to the mark with the same diluent and mix well. Inject into the chromatographic system. The chromatogram obtained is shown in (Figure 2).

Figure 2 HPLC chromatogram of (1.0μg/mL) of AMO.

Instruments and chromatographic system: HPLC system (Agilent 1260 Infinity, Germany) instrument is equipped with an Agilent 1260 Infinity preparative pump (G1361A), Agilent 1260 Infinity DAD detector VL (G131SD), Agilent 1260 Infinity Thermostated column compartment (G1316A) and Agilent 1260 Infinity preparative Autosampler (G2260A) was performed using Betabasic - 4.6-mmx25-cm; 5μm packing L1. Adjust the flow rate to 1.5mL/min using UV Detector adjusted at 230nm with column temperature 8ºC and injection volume of 100μL.

  1. UV-1800 with high software UV-Probe 2.5 (Shimadzu model)
  2. Mettler pH Meter.
  3. Shimadzu analytical balance.
  4. Ultra-sonic bath.
  5. NICOMAC Coating Machine.

Mobile phase preparation: Dissolve about 10.1g of dihydrogen sodium phosphate dihydrate in 900mL of deionized water. Adjust the pH to 4.4±0.1 with H3PO4. Complete the volume to 1000mL using deionized water. Mix 950mL of dihydrogen sodium phosphate buffer with 50mL of methanol. Filter through a 0.45µm membrane filter.

Construction of standardization curves: Various aliquots of AMO in the range 0.03–6.0µg/mL, are independently transferred from their particular stock standard solutions into separate series of 100mL volumetric flasks and volume is completed to the mark with the diluent and shaked well. Triplicate 100µL injections are executed for every concentration keeping the flow rate at 1.5mL/min and the UV detection at 230nm. The chromatographic system is accomplished using the technique under chromatographic system. The chromatograms are assigned and area under peaks of AMO are determined and the calibration curves are conducted and the regression equations are processed.

Test preparation: To simulate the manufacturing equipment, SS-316 plate (5.08 x 5.08cm2 area) is cut from the SS–316 sheets and is used for all recovery studies. These studies are performed on the SS-316 plate (5.08x5.08cm2 area) by applying solutions of different concentrations (equivalent to 0.1µg/mL, 1.0µg/mL and 10µg/mL) of AMO by using a syringe and drying the plate in air. The plate is swabbed with a swab pre-moistened with methanol vertically and horizontally as shown in (Figure 3). Transfer the cotton swap to HDPE  (high density polyethylene) bottle using clean forceps. Add 5mL of deionized water to the bottle. Close with a white cap. Shake the bottle for about 5 minutes. Fill the vial then analyze by HPLC.

Figure 3 Swabbing pattern.

Results and discussion

Methods development and optimization

System optimization: The selection of mobile phase and the chromatographic system is dedicated to the good separation and resolution, so several conditions have been tested and comprehension different compositions of: (100%) organic solvent, (50:50, v/v); organic solvent: water. Every one of the solvents of the portable stage is filtered through 0.45μ membrane filter paper to expel particulate issue and degassed by sonication, additionally (0.6, 1.2, 1.4 and 1.5mL/min) flow rates were attempted. To get the ideal wavelength of 20µg/mL AMO, the system was optimized within range 200-400nm as showed in (Figure 4). In this manner, 230nm is chosen as the most appropriate absorbance. Preparatory examinations included attempting C18 L1 packing. The best developing system is 0.05M sodium dihydrogen phosphate: methanol (95:5 v/v) adjusted to pH 4.4 with ortho phosphoric acid at a flow rate of 1.5mL/min, injection volume 100μL, the retention time of AMO is 6.292 min and the total run time is 7 min. This selected developing system allows good separation with good Rt values without tailing of the separated bands and good theoretical plates.

Figure 4 Linearity spectra of Amoxicillin using deionised water as a blank.

Cleaning validation for NICOMAC coating machine: Nowadays pharmaceutical products are manufactured in multi-use facility. FDA protects and promotes public health. Cleaning validation program ensures absence of residues of reaction byproducts and degrades from the previous process/product. The most appropriate cleaning procedure should be developed for the equipment to minimize the cross contamination and there is also necessity to develop and validate the sampling and chosen analytical methods for the compound(s) being cleaned for rinse and swab sampling. Along with taking samples, it is important to perform visual inspection as well to ensure the process acceptability.

Swab sampling: Direct surface sampling can be carried out in several ways, but the most common and widely accepted is swabbing. This involves wiping a predetermined area of the NICOMAC Coating Machine with a swab that has been moistened with a solvent bearing the contaminating compound. Usually the surface is wiped with one side of the swab using a certain number of strokes, then the swap is flipped and the surface is wiped at 90° to the first series of strokes as shown in (Figure 3). Selection of swab is an important part during the cleaning validation program and to maximize the recovery. Two types of swabs are studied–Himedia (having circle head) and Texwipe (having flat head) as shown in (Figure 5). This method of sampling is the most commonly used and involved taking an inert material (eg., cotton wool) at the end of the probe (referred to as swab) and rubbing it methodically across the surface as machine body, hopper, guns, pipes and control panel (Figure 6) The results are represented in Table. 1.

Figure 5 Two types of swabs were studied–Himedia (having circle head) and Texwipe (having flat head).

Figure 6 Chromatogram of (a) blank Texwipe swab, (b) Machine body, (c) hopper, (d), guns, (e) pips and (f) control panel.

Rinse sampling: A measured area of a cleaned surface is rinsed or solvent washed and the solvent is collected and tested for traces of contaminants as shown in (Figure 7).

Figure 7 Rinse sampling method.

Method validation

Recently, we have published the validation of Cefaclor.42 The present method was, similarly, validated in accordance with ICH guidelines (ICH Q2R1), for system suitability, precision, accuracy, linearity, specificity, ruggedness, robustness, LOD and LOQ.43

Linearity and range

The linearity of the proposed method is obtained in the concentration range (0.03-6.0μg AMO/mL). Calibration curves are constructed by plotting the obtained peak areas against the corresponding concentrations. The obtained coefficient of regression is 0.9989. Results of linearity are recorded in Table 2.

Serial

Machine Part

Location

Sampling Procedure

Results

1

Machine Body

Front side

Swab

No Peak Detected

Top side

Left side

Right side

 

Bottom side

 

2

Mixing Container 1

Inside

Outside

3

Mixing Container 2

Inside

Outside

4

Air Stirrer (Inside Pan)

Air stirrer (Inside Pan)1

 

 

Air stirrer (Inside Pan)2

 

 

5

Inside Coating Pan

 

6

Baffles (inside Pan)

 

7

Hopper

8

Guns

Gun 1

Gun 2

9

Pips

Pipe 1

Pipe 2

Pipe 1

10

Control Panel

Top side

Bottom side

 

Left side

Right side

 

Between control

 

Table 1 NICOMAC coating machine cleaning results by using HPLC

Parameter

AMO

 Linear

range (ppm)

0.03-6

Slope

86.6517

Intercept

4.0758

Correlation coefficient

0.9989

LOD a (µg/mL)

0.05

LOQ a (µg/mL)

0.15

Repeatability b

0.101

Table 2 Regression and validation parameters of the proposed HPLC method for determination of AMO

aLimit of detection (3.3× σ /Slope) and limit of quantitation (10× σ /Slope).
bRepeatability for n≥5, RSD ≤2.

Precision

Six injections from the working standard solution of AMO 1.0μg/mL was successfully performed, where the RSD below 2.0% as mentioned in the below Table 2.

LOD and LOQ

Many methods are reported to verify LOD and LOQ but the important one is by using calibration curve and regression equation. Diluted standards of AMO solution of 0.05μg/mL, 0.1μg/mL and 0.2μg/mL are prepared for verification of the detection and quantification of the method. Each diluted standard solution is measured in triplicates as shown in (Figure 8).The residual standard deviation of a regression line or the standard deviation of y-intercepts of regression lines may be used as the standard deviation. LOD =3.3×σ /slope and LOQ=10×σ/slope, where σ=the standard deviation of the response as illustrated in Table 2.

Figure 8 Chromatogram of detection limit.

Accuracy and recovery

Accuracy is studied by comparing the area of spiked solutions of 0.1, 1.0, and 10µg AMO/mL in solvent with the area of standard AMO in the range of 0.1, 1.0, and 10µg/mL. These data are presented in Table 3. The percent recovery is found to be in the range of 85% to 105%.

Level (ppm)

Preparation

Amoxicillin (%)

Recovery

0.1

1

88.01

2

86.7

3

85.25

Mean

86.65

1

1

100.85

2

100.72

3

100.63

Mean

100.73

5

1

102.48

2

102.47

3

102.47

Mean

102.47

Table 3 Data of accuracy for AMO

Lab variation method

Ruggedness of the method indicates that the method remains unaffected by small variation in the method parameters as change from day to day, analyst to analyst and different codes in HPLC apparatus, thus the collected data are recorded in codes Table 4.

Parameter(%RSD)

AMO

Intraday

0.118

Interday

0.998

Analyst to analyst

0.114

Column to column

0.869

Table 4 Ruggedness of the method

Robustness

Robustness indicates that the changes occurred to the method within the same laboratory. However, robustness can also be characterized as the probability to supersede the analytical method in different laboratories or under different conditions without the status of unusual differences in the obtained results as mentioned in Table 5.

Parameter(%RSD)

AMO

Flow rate change (±0.1mL/min)

1.770

pH change of mobile phase (±0.2)

1.391

Wave length change (230±1.0nm)

0.332

Column temperature change(30º±5C)

0.652

Table 5 Robustness of the method

System suitability

The system of the method can be achieved by verification of different factors as injection precision, resolution, theoretical plate and tailing factor, the results and calculated data are presented in the below Table 6.

Item

Obtained value

Reference values

AMO

Tailing factor

1.07

T ≤ 2

Selectivity

4

k’ > 2

Injection precision

0.103

RSD ≤1%

Retention time (Rt)

0.04

RSD ≤1%

Number of theoretical plates(N)

10366.59

N > 2000

Table 6 System suitability testing parameters of the developed method

Analyte stability

Analyte stability is used to measure and verify that the solution remains stable under different storage conditions as room temperature against fridge and fresh sample, the obtained results are recorded in the below Table 7.

Condition

AMO

Fridge (2-8°C)

98.22%

Room temperature (25°C)

97.10%

Table 7 Result of stability of analytical solution

Selectivity

An analytical method is considered selective if its calculated data are not changed by other sample components to any significant extent. Compounds, other than analyte, which participate in the analytical signal, are called interfering compounds or interferents. The calculated data are mentioned in the Table 8.

Name

Amoxicillin

Effect

Observed tR

Peak area

Degradation %

Test

Without effect (control)

6.292

89.83479

-

Oxidation effect

6.254

79.9876

10.96

Alkali effect

6.266

74.6756

16.87

Acid effect

6.281

85.2454

5.10

Light effect (Sun light)

6.289

86.2132

4.03

Heat effect

6.283

87.8778

2.17

Placebo

No peak observed

No peak observed

-

Table 8 Results of analysis of forced degradation study samples using proposed method, indicating percentage degradation of AMO

Light degeneration: Accurately weigh 50mg of AMO standard powder previously kept under sunlight for 48 hours and transfer to 50-mL volumetric flask. Add 35mL of the solvent, sonicate to dissolve. Accurately transfer 1.0mL from this stock standard solution of AMO to 1000mL volumetric flask, add diluent and sonicate to dissolve. Shake well and filter, then inject the vials into the HPLC system.

Heat treatment: Retain suitable quantity of AMO working standard in dry oven below 100ºC for six hrs. until all moisture has been driven off and the weight is constant. After cooling to room temperature in a desiccator, accurately weigh 50mg of this powder and transfer to 50-mL volumetric flask. Add 35mL of solvent, sonicate to dissolve and complete to the mark with solvent. Accurately transfer an aliquot of 1.0mL this of AMO into 1000mL volumetric flask, add diluent and sonicate to dissolve. Make up to the mark with the same diluent and mix well. Filter as usual, furthermore inject the vials into HPLC system.

Acid treatment: Accurately transfer 1.0mL from the standard stock solution of AMO into 1000mL volumetric flask, add 100mL of 0.1M HCl furthermore store the acidified solution at warm place for one day. Makeup to the mark. Shake well and filter, then inject the vials into HPLC system.

Alkaline treatment: Accurately transfer 1.0mL from the standard stock solution of AMO into 1000mL volumetric flask, add 100mL of 0.1M sodium hydroxide then keep the basic solution at room temperature for 24 hr. Shake well and filter, then inject the vials into the HPLC system.

H2O2 degradation: Accurately transfer 1.0mL from the standard stock solution of AMO into 1000mL volumetric flask, add 75mL of 3.0% H2O2 then keep at room temperature for two days. Shake well and filter, then inject the vials into the HPLC system.

Conclusion

The proposed RP-HPLC method for the determination of AMO residues in NICOMAC coating machine is precise, specific, accurate and simple and may be successfully applied to quality control analyses during cleaning validation activity as well as routine cleaning programs. Swab recovery study is successfully developed and satisfactory results have been obtained. The results of forced degradation undertaken according to the (ICH) guidelines revealed that the method is selective and can be used for regular routine analysis and stability studies.

Compliance with ethical standards

Funding

No funding.

Ethical approval

This article does not contain any studies with animals performed by any of the authors.

Acknowledgements

The authors are thankful to the Publishers of the Journal of Analytical & Pharmaceutical Research, MedCrave Group for the publication gift provided.

Conflict of interest

All authors declare that they have no conflict of interest.

References

  1. British Pharmacopoeia. Stationary Office, Medicines and Healthcare Products Regulatory Agency. London; 2017.
  2. https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM205893
  3. European Pharmacopeia. 8th edition. 2014.
  4. The United States Pharmacopoeia Convention Inc. The United States Pharmacopoeia. 38th Revision. 2015.
  5. Chadha R, Kashid N, Jain DV. Kinetic studies of the degradation of an aminopenicillin antibiotic (amoxicillin trihydrate) in aqueous solution using heat conduction microcalorimetry. J Pharm Pharmacol. 2003;55(11):495–503.
  6. Vahdat L, Sunderland VB. Kinetics of amoxicillin and clavulanate degradation alone and in combination in aqueous solution under frozen conditions. Int J Pharm. 2007;342(1–2):95–104. 
  7. Emad SE, Malay C. Degradation of amoxicillin, ampicillin and cloxacillin antibiotics in aqueous solution by the UV/ZnO photocatalytic process. J Haz Mat. 2010;173:445–449.
  8. Wasan AA. Spectrophotometric Determination of Amoxicillin in Pharmaceutical preparations through diazotization and coupling reaction. Iraqi J Sci. 2012;53(4):713–723.
  9. Prakash K, Raju PN, Kumari KS, et al. Spectrophotometric Estimation of Amoxicillin Trihydrate in Bulk and Pharmaceutical Dosage Form. E–Journal of Chemistry. 2008;5(S2):1114–1116.
  10. Quanmin L, Zhanjun Y. Study of Spectrophotometric Determination of Amoxicillin Using Sodium 1,2‐Naphthoquinone‐4‐Sulfonate as the Chemical Derivative Chromogenic Reagent. Anal Lett. 2006;39(4):763–775.
  11. Al–Abachi MQ, Haddi H, Al–Abachi AM. Spectrophotometric determination of amoxicillin by reaction with N, N–dimethyl–p–phenylenediamine and potassium hexacyanoferrate(III). Anal Chim Acta. 2005;554(1–2):184–189.
  12. Othman NS, AL–Saffar RS. Spectrophotometric Determination of Amoxicillin in Pharmaceutical Preparations. Int J Enhan Res Sci Technol & Eng. 2015;4(6):167–173.
  13. Singh DK, Maheshwari G. Spectrophotometric determination of penicillins in pure and pharmaceutical formulations using Folin–Ciocalteu reagent. Drug Test Anal. 2010;2(10):503–600.
  14. Tiphaine L, Dominique V, Nicolas T, et al. Simultaneous Determination of Eight β–Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra–High–Performance Liquid Chromatography with Ultraviolet Detection. Antimicrob. Agents Chemother. 2016;60(8):4734–4742.
  15. Darshan VC, Daxesh PP, Jaivik VS, et al. Analysis of Amoxicillin and Clavulanic Acid by UPLC–MS/MS in Human Plasma for Pharmacokinetic Application. J of Modern Drug Discovery and Drug Delivery Research (JMDDR). 2015;2(3):1–10.
  16. Cirić B, Jandrić D, Kilibarda V, et al. Simultaneous determination of amoxicillin and clavulanic acid in the human plasma by high performance liquid chromatography–mass spectrometry. Vojnosanit Pregl. 2010;67(11):887–892.
  17. Khuroo AH, Monif T, Verma PR, et al. Simple, economical, and reproducible LC–MS method for the determination of amoxicillin in human plasma and its application to a pharmacokinetic study. J Chromatogr Sci. 2008;46(10):854–861.
  18. Chaitanya KA, Chelladurai R, Jeevanantham S, et al. A Novel and High–Throughput Method for the Simultaneous Determination of Amoxicillin and Clavulanic Acid in Human Plasma by Liquid Chromatography Coupled with Tandem Mass Spectrometry. Int J Pharm Pharm Sci. 2012;4(3):648–652.
  19. Yaxin F, Xiaojie W, Miao Z, et al. Rapid and Simultaneous Quantitation of Amoxicillin and Clavulanic Acid in Human Plasma and Urine by Ultra–Performance Liquid Chromatography Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study. Anal Sci. 2016;32:1269–1276.
  20. Ghoulipour V, Shokri M, Waqif–Husain S. Determination of Ampicillin and Amoxicillin by High–Performance Thin–Layer Chromatography. Acta Chromatogr. 2011;23(3):483–498.
  21. Hancu G, Simon B, Kelemen H, et al. Thin Layer Chromatographic Analysis of Beta–Lactam Antibiotics. Adv Pharm Bull. 2013;3(2):367–371.
  22. Petkova V, Tsvetkova DD, Obreshkova DP, et al. Validation of TLC – Densitometric Method for Quality Control of Amoxicillin in Dosage Drug Products. World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS). 2014;3:995–1008.
  23. Hancu G, Neacşu A, Papp LA, et al. Simultaneous determination of amoxicillin and clavulanic acid in pharmaceutical preparations by capillary zone electrophoresis. Braz J Pharm Sci. 2016;52(2):281–286.
  24. Marra MC, Cunha RR, Muñoz RAA, et al. Single–run capillary electrophoresis method for the fast–simultaneous determination of amoxicillin, clavulanate, and potassium. J Sep Sci. 2017; 40(17):3557-3562.
  25. Hernández M, Borrull F, Calull M. Determination of amoxicillin in plasma samples by capillary electrophoresis. J Chromatogr B Biomed Sci Appl. 1999;731(2):309–315.
  26. Injac R, Kočevar N, Štrukelj B. Optimized Method for Determination of Amoxicillin, Ampicillin, Sulfamethoxazole, and Sulfacetamide in Animal Feed by Micellar Electrokinetic Capillary Chromatography and Comparison with High–Performance Liquid Chromatography. Croat Chem Acta. 2009;82(3):685–694.
  27.  Manzoor A, Suresh BG, Sathish KSA. Development and Validation of Amoxicillin by RP–HPLC Method in Bulk drug and Pharmaceutical dosage forms. Int J Chem Tech Res. 2011;3(3):1037–1041.
  28. Tavakoli N, Varshosaz J, Dorkoosh F, et al. Development and validation of a simple HPLC method for simultaneous in vitro determination of amoxicillin and metronidazole at single wavelength. J Pharm Biomed Anal. 2007;43(1):325–329.
  29. Batrawi N, Wahdan S, Al–Rimawi F. A Validated Stability–Indicating HPLC Method for Simultaneous Determination of Amoxicillin and Enrofloxacin Combination in an Injectable Suspension. Sci Pharm. 2017;85(1):6.
  30. Hsu MC, Hsu PW. High–Performance Liquid Chromatographic Method for Potency Determination of Amoxicillin in Commercial Preparations and for Stability Studies. Antimicrob Agents Chemother. 1992;36(6):1276–1279.
  31. Jayakar B, Kumudhavalli MV, Chandira RM, et al. Method Development and Validation of Rp–Hplc Method for Simultaneous Determination of Amoxycillin and Potassium Clavulanate. Int J Pharm Tech Res. 2010;2(1):906–909.
  32. Kassaye L, Genete G. Evaluation and comparison of in–vitro dissolution profiles for different brands of amoxicillin capsules. Afr Health Sci. 2013;13(2):369–375.
  33. Silva RL, Souza RS, Teles ALB, et al. Comparative In Vitro Analysis of Dissolution Profiles of Pharmaceutical Formulations Containing Amoxicillin. Lat Am J Pharm. 2013;32(3):358–363.
  34. Emara LH, Abdou AR, El–Ashmawy AA, et al. In Vitro Release Evaluation of Gastroretentive Amoxicillin Floating Tablets Employing a Specific Design of the Flow–Through Cell. Dissolut Technol. 2013.
  35. Al–Tabakha MM, Fahelelbom KMS, Obaid DEE, et al. Quality Attributes and In Vitro Bioequivalence of Different Brands of Amoxicillin Trihydrate Tablets. Pharmaceutics. 2017;9(2):18.
  36. Hailu GS, Gutema GB, Ali YS, et al. Comparative In vitro Bioequivalence Evaluation of Different Brands of Amoxicillin Capsules Marketed in Tigray, Ethiopia. Int J Pharm Sci Nanotech. 2013;6(1):1966–1971.
  37. Luo W, Ang CY. Determination of Amoxicillin Residues in Animal Tissues by Solid–Phase Extraction and Liquid Chromatography with Fluorescence Detection. J AOAC Int. 2000;83(1):20–25.
  38. Rose MD, Tarbin J, Farrington WHH, et al. Determination of penicillins in animal tissues at trace residue concentrations: II. determination of amoxicillin and ampicillin in liver and muscle using cation exchange and porous graphitic carbon solid phase extraction and high‐performance liquid chromatography. Food Addit Contam. 1997;14(2):127–133.
  39. Xie K, Zhao M, Guo H, et al. Determination and depletion of amoxicillin residue in eggs. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2013;30(4):670–677.
  40. Liu YN, Pang MD, Xie X, et al. Residue depletion of amoxicillin and its major metabolites in eggs. J vet Pharmacol Ther. 2016;40(4):383–391.
  41. Irum A, Saeed H, Ali S, et al. Estimation of Amoxicillin Residues in Commercial Meat and Milk Samples. J Microbiol Biotech Food Sci. 2014;4(1):48–50.
  42. Mahmoud AM, Amr HA, Abdelfatah MA, et al. Validation and Comparative In–vitro Dissolution Studies of Cefaclor in Their Powder for Oral Suspension Dosage Forms. Anal Chem Lett. 2018;8(1):88–103.
  43. ICH, Q2 (R1). Validation of Analytical Procedures: Text and Methodology. ICH Harmonized Tripartite Guideline. 2005.
Creative Commons Attribution License

©2018 Hassouna, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.